Affiliated Managers Group, Inc., through its affiliates, operates as an investment management company providing investment management services to mutual funds, institutional clients,retails and high net worth individuals in the United States. It provides advisory or sub-advisory services to mutual funds. These funds are distributed to retail, high net worth and institutional clients directly and through intermediaries, including independent investment advisors, retirement plan sponsors, broker-dealers, major fund marketplaces, and bank trust departments. The company also offers investment products in various investment styles in the institutional distribution channel, including small, small/mid, mid, and large capitalization value and growth equity, and emerging markets. In addition, it offers quantitative, alternative, and fixed income products, and manages assets for foundations and endowments, defined benefit, and defined contribution plans for corporations and municipalities. Affiliated Managers Group provides investment management or customized investment counseling and fiduciary services. Affiliated Managers Group, Inc. was formed in 1993 and is based in West Palm Beach, Florida with additional offices in Prides Crossing, Massachusetts; Stamford, Connecticut; London, United Kingdom; Dubai, United Arab Emirates; Sydney, Australia; Hong Kong; Tokyo, Japan, Zurich, Switzerland and Delaware.

Affiliated Managers Group Inc.

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has launched a phase 1b study in small cell lung cancer that test...

Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study

Amgen ( ($AMGN) ) has provided an update. At its annual meeting held on May 19, 2026, Amgen stockholders re-elected all 12 director nominees to one...

Amgen Shareholders Reaffirm Board, Pay and Auditors

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen is running a new early-stage trial called “A Phase 1b, Open-label Stud...

Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer

Amgen Inc (($AMGN)) has held its Q1 earnings call. Read on for the main highlights of the call. Amgen Inc.’s latest earnings call struck a cautious...

Amgen Earnings Call Highlights Growth Amid Headwinds

Amgen ( ($AMGN) ) has provided an announcement. Amgen announced on May 19, 2026 that Executive Vice President and Chief Financial Officer Peter Gri...

Amgen Announces CFO Transition and Leadership Succession Plan

In a report released today, William Katz from TD Cowen maintained a Buy rating on Affiliated Managers, with a price target of $454.00. Katz covers ...

TD Cowen Remains a Buy on Affiliated Managers (AMG)

Last week, stocks pushed to fresh highs as strong jobs data and gains in chip stocks helped lift the market. The S&P 500 (SPX) rose 0.84% to 7,397....

The Week That Was, The Week Ahead: Macro and Markets, May 10

Vanguard S&P 500 ETF ($VOO) remains one of the most popular choices for investors seeking broad exposure to the U.S. stock market. However, as mark...

Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026

Quantinuum, a quantum computing firm backed by industrial conglomerate Honeywell ($HON), has filed for a U.S. IPO as it looks to take advantage of ...

Honeywell-Backed Quantinuum Files for IPO amid Quantum Computing Excitement

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eton Pharmaceuticals (ETON), Amgen (AMGN) and Brig...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eton Pharmaceuticals (ETON), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG)

In a report released yesterday, Vamil Divan from Guggenheim maintained a Hold rating on Amgen, with a price target of $340.00. According to TipRank...

Guggenheim Sticks to Their Hold Rating for Amgen (AMGN)

BMO Capital analyst Evan Seigerman maintained a Buy rating on Amgen today and set a price target of $400.00. Seigerman covers the Healthcare sector...

Amgen (AMGN) Gets a Buy from BMO Capital

TD Cowen Sticks to Their Buy Rating for Affiliated Managers (AMG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen (AMGN) and BridgeBio Pharma (BBIO) with bullis...

Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), BridgeBio Pharma (BBIO)

In a report released yesterday, from Raymond James assigned a Hold rating to Amgen. The company’s shares closed yesterday at $329.82. Amgen has an ...

Raymond James Issues a Hold Rating on Amgen (AMGN)

Amgen Inc (($AMGN)) has held its Q1 earnings call. Read on for the main highlights of the call. Amgen’s latest earnings call struck a cautiously up...

Amgen Earnings Call Highlights Growth Engines, Tax Risk

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Mastercard (MA) and Affiliated Managers (AMG) with bu...

Wall Street Analysts Are Bullish on Top Financial Picks

J.P. Morgan analyst initiated coverage with a Hold rating on Amgen today and set a price target of $300.00. In addition to J.P. Morgan, Amgen also ...

Amgen (AMGN) Gets a Hold from J.P. Morgan

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN), Immunome (IMNM) and Resmed (RMD). Amgen (AMGN) RBC ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Immunome (IMNM) and Resmed (RMD)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Dexcom (DXCM) and Merit Medical Syst...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merit Medical Systems (MMSI)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Alnylam Pharma (ALNY) and The Ensign...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Alnylam Pharma (ALNY) and The Ensign Group (ENSG)

Bank of America Securities analyst Tazeen Ahmad reiterated a Sell rating on Amgen today and set a price target of $307.00. Ahmad covers the Healthc...

Bank of America Securities Keeps Their Sell Rating on Amgen (AMGN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Weave Communications (WEAV) and Orth...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Weave Communications (WEAV) and OrthoPediatrics (KIDS)

Amigo Holdings PLC ( ($GB:AMGO) ) has issued an announcement. Amigo Holdings PLC, a London-listed miner focused on gold and rare earth opportunitie...

Amigo Holdings Moves Registered Office to Central London

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN) and Icon (ICLR). Amgen (AMGN) In a report released y...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Icon (ICLR)

MetalNRG Plc ( ($GB:AMG) ) just unveiled an update. Atlas Metals Group plc has released its Annual Report and Financial Statements for the year end...

Atlas Metals Group Publishes 2025 Annual Report and Accounts

The U.S. Food and Drug Administration (FDA) is looking to deploy artificial intelligence to achieve real-time evaluation of clinical trial results ...

FDA Recruits AstraZeneca, Amgen in Bet on AI to Accelerate Drug Development

In a report released today, Alexander Paris from Barrington reiterated a Buy rating on Affiliated Managers, with a price target of $365.00. Accordi...

Market Cap	$7.29B	P/E Ratio	9.00
52W High	$334.78	52W Low	$172.54
Div Yield	4.0%	Payout Ratio	0.1%
EPS Growth 3Y	-5.4%	52W Position	83.9%
Overall Score	66	Value Score	80
Quality Score	60	Technical Score	60

EPS Current Est	$34.31	EPS Next Est	$38.72
EPS Growth Est	+12.9%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMG	$308.65	+2.22%	227.61K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AMG	$308.65	+2.2%	227.61K
3
4
5
6

AMG

AMG

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Affiliated Managers Group Inc. Data in Excel

Get Affiliated Managers Group Inc. Data in Excel